Why Viveve Medical's Stock Is Trading Lower Today

Viveve Medical VIVE shares are trading lower on Thursday, after the company announced that the vive pivotal VIVEVE 2 study did not meet its primary endpoint.

Viveve Medical designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions.

Viveve Medical shares were trading down 26.85% at 63 cents on Thursday. The stock has a 52-week high of $76 and a 52-week low of 54 cents.

Related Link:

Viveve Medical Shares Plummet After Trial Misses Primary Endpoint